These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 27117590)

  • 21. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
    Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
    Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
    Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating serum exosomal miR-20b-5p and miR-3187-5p as efficient diagnostic biomarkers for early-stage non-small cell lung cancer.
    Zhang ZJ; Song XG; Xie L; Wang KY; Tang YY; Yu M; Feng XD; Song XR
    Exp Biol Med (Maywood); 2020 Oct; 245(16):1428-1436. PubMed ID: 32741216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer.
    Hawkins PG; Sun Y; Dess RT; Jackson WC; Sun G; Bi N; Tewari M; Hayman JA; Kalemkerian GP; Gadgeel SM; Lawrence TS; Haken RKT; Matuszak MM; Kong FS; Schipper MJ; Jolly S
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1635-1643. PubMed ID: 30923943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer.
    Dong X; Chang M; Song X; Ding S; Xie L; Song X
    Thorac Cancer; 2021 Feb; 12(4):539-548. PubMed ID: 33372399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating miR-21-5p and miR-126-3p: diagnostic, prognostic value, and multivariate analysis in non-small-cell lung cancer.
    Soliman SE; Abdelaleem AH; Alhanafy AM; Ibrahem RAL; Elhaded ASA; Assar MFA
    Mol Biol Rep; 2021 Mar; 48(3):2543-2552. PubMed ID: 33837901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.
    Lee IH; Kim G; Kwak SG; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Hur K; Kim JG
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells.
    Tang Y; Cui Y; Li Z; Jiao Z; Zhang Y; He Y; Chen G; Zhou Q; Wang W; Zhou X; Luo J; Zhang S
    J Exp Clin Cancer Res; 2016 Jan; 35():7. PubMed ID: 26754670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
    Jiang L; Huang Q; Zhang S; Zhang Q; Chang J; Qiu X; Wang E
    BMC Cancer; 2010 Jun; 10():318. PubMed ID: 20569443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapy.
    Malla B; Aebersold DM; Dal Pra A
    J Transl Med; 2018 Aug; 16(1):223. PubMed ID: 30103771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production.
    Ghofrani-Shahpar M; Pakravan K; Razmara E; Amooie F; Mahmoudian M; Heshmati M; Babashah S
    BMC Cancer; 2024 Apr; 24(1):400. PubMed ID: 38561726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-suppressive miR-4732-3p is sorted into fucosylated exosome by hnRNPK to avoid the inhibition of lung cancer progression.
    Zhuang W; Liu C; Hong Y; Zheng Y; Huang M; Tang H; Zhao L; Huang Z; Tu M; Yu L; Chen J; Zhang Y; Chen X; Lin F; Gao Q; Yu C; Huang Y
    J Exp Clin Cancer Res; 2024 Apr; 43(1):123. PubMed ID: 38654325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer.
    Wang N; Guo W; Song X; Liu L; Niu L; Song X; Xie L
    Clin Chem Lab Med; 2020 Aug; 58(9):1535-1545. PubMed ID: 32271158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
    Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
    Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer.
    Liu X; Chu KM
    J Cell Mol Med; 2020 Jun; 24(11):6220-6232. PubMed ID: 32383554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the Oncogenic LINE-1 Regulatory Network in Non-Small Cell Lung Cancer by Exosomal miRNAs.
    Hassanin AAI; Ramos KS
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
    Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M
    Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients.
    Bache M; Kadler F; Struck O; Medenwald D; Ostheimer C; Güttler A; Keßler J; Kappler M; Riemann A; Thews O; Seliger B; Vordermark D
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.